Discover 2,414 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,414
Rapid Evacuation and Access of Cerebral Hemorrhage Trial
Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
for
Acute Ischemic Stroke
Location: Baltimore MD, Durham NC, Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18+
Code: NCT06440707
Phase2, Recruiting
Evaluating the Status of Complex Aneuploidy to Locate Additional Transferrable Embryos
for
Complex Aneuploidy, Chaotic Aneuploidy
Location: Rockville MD, Fairfax VA, Towson MD, Richmond VA,
Sponsor: Shady Grove Fertility Reproductive Science Center
Sex: All
Age: 0+
Code: NCT07227116
Recruiting
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
for
Infertility (IVF Patients)
Location: Rockville MD, Bryn Mawr PA, Raleigh NC, Norwalk CT,
Sponsor: Granata Bio Corporation
Sex: Female
Age: 18 - 42
Code: NCT07216742
Phase3, Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
for
Cardiovascular Disease
Location: Beltsville MD, Fairfax VA, Falls Church VA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07000357
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
for
Asthma
Location: Silver Spring MD, Ellicott City MD, White Marsh MD,
Sponsor: AstraZeneca
Sex: All
Age: 12 - 17
Code: NCT06307665
Phase3, Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Silver Spring MD, Fairfax VA, Charlottesville VA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase3, Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
for
Plaque Psoriasis
Location: Rockville MD, Camp Hill PA, Pittsburgh PA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 40+
Code: NCT07116967
Phase3, Recruiting
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
for
Lupus Nephritis
Location: Rockville MD, Willow Grove PA, West Long Branch NJ,
Sponsor: Aurinia Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07611214
Recruiting
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
for
Lung Neoplasm
Location: Fairfax VA, Baltimore MD, Lexington KY, Dallas TX
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780098
Phase2, Recruiting
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
for
Radiographic Axial Spondyloarthritis
Location: Rockville MD, Baltimore MD, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07133633
Phase2, Recruiting
Environment and Alcohol: A Pilot Study
for
Alcohol Use Disorder
Location: Baltimore MD
Sponsor: National Institute on Drug Abuse (NIDA)
Sex: All
Age: 21 - 70+
Code: NCT06860607
Phase1, Recruiting
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
for
Systemic Lupus Erythematosus (With and Without Nephritis),
Location: Baltimore MD, East Brunswick NJ, New York NY, Durham NC,
Sponsor: Allogene Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07085104
Phase1, Recruiting
Testicular Evaluation of Azoospermia Using Micro-Ultrasound
for
Azoospermia
Location: Rockville MD, Edmonton
Sponsor: Paul Shin
Sex: Male
Age: 18+
Code: NCT06941922
Recruiting
Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)